Introduction
Healthcare-associated infections (HAIs) are a major patient safety issue in hospitals. While research into infection prevention and control has led to improvements in our understanding of effective HAI prevention strategies [1] , HAIs continue to occur and lead to morbidity, mortality and excess healthcare expenditure [1, 2] . Unlike most developed countries, Australia does not have a national system to monitor these infections and cannot provide an estimate of the burden of hospital-acquired HAIs. The last national point prevalence study conducted in Australia occurred in 1984 [3] . Healthcare delivery, technology and infection prevention and control initiatives have advanced considerably since this time.
In 2008, Cruickshank and Ferguson [4] estimated that there are about 200,000 HAIs each year in Australia, which if correct makes them the most common complication affecting patients in hospital. There has not been a subsequent evidence-based estimate of the incidence of HAIs in Australia despite HAIs being widely reported as the most common complication affecting patients in hospital globally. The purpose of this systematic review was to explore the burden of HAIs in Australian hospitals by determining the incidence of HAIs in Australian hospitals, as reported in the peer-reviewed literature from 2010 to 2016.
Methods

Protocol and registration
The protocol for this review is registered with PROSPERO, an international prospective register of systematic reviews (available at http://www.crd.york.ac.uk/prospero/ with registration number: CRD42016052997). Ethics approval was not sought because this review used data from published studies.
Search strategy
A systematic search was conducted using the electronic databases MEDLINE (PubMed) and the Cumulative Index to Nursing and Allied Health Literature (CINAHL) to search for articles published between 1 January 2010 and 31 December 2016. The timeframe was chosen to include the most current HAI data. During the 2000s, a number of state and national initiatives were undertaken to reduce HAIs, including the national hand hygiene initiative, development of National Health and Medical Research Council guidelines, revision of hospital accreditation standards, surveillance initiatives and public reporting of some infection data [5e7] . Reference lists of eligible articles relating to these initiatives were reviewed to identify any additional articles.
To identify articles from MEDLINE and CINAHL, the search terms "surveillance", "incidence", "prevalence", "frequency", "rates or statistics" and "performance indicators" were used in combination with "nosocomial infection", "hospital acquired infection", "healthcare associated infection", "cross infection" and "infection". To identify and limit the search to articles from Australian hospitals, the search term "hospital" was used with "Australia", "Australian", "Queensland", "New South Wales", "Australian Capital Territory", "Victoria", "Tasmania", "South Australia", "Western Australia" and "Northern Territory". These terms were applied using an all text search. For the MEDLINE search, the MeSH terms "epidemiology", "cross Infection" and "disease transmission, infectious" were also used.
Inclusion criteria
Articles were eligible if they reported the results of cohort studies, case-control studies, cross-sectional studies, randomised controlled trials or case reports (reporting incidence) of HAI. For this study, cohort studies include studies where a population is followed up to determine whether they subsequently acquire an infection. To be eligible, data collection had to occur after 1 January 2010. Articles were limited to studies conducted in Australian hospitals. For international or multi-centre studies, data from Australian hospitals was included if the data was reported at this level. Where Australia-specific data was not available, the study was excluded.
Exclusion criteria
The following exclusion criteria applied: all grey literature, non-peer reviewed, conference abstracts, papers written in languages other than English, reviews, editorials, commentaries or policy statements.
Definitions
For this review, the definition of HAI used in the articles must have referenced a recognised standard such as a definition agreed or published by professional association or government agency, a definition widely used in the published literature or an ICD10 code that constitutes a HAI (not any infection). Any disputes about whether an article had used an appropriate definition were resolved by discussion among the reviewers.
Study selection
The titles and abstracts of the articles identified from MED-LINE and CINAHL were examined and assessed for relevance and appropriateness to the review question by one reviewer (CW). Those not relevant were excluded. For a random selection (10%) of articles, the abstracts were independently reviewed by another reviewer (BM) to identify any discrepancies; none were identified. Of the remaining articles, a full text review was undertaken (CW) to assess eligibility. Where there was uncertainty as to whether an article should be included, two researchers independently reviewed the articles (PR and RS). If there was disagreement, a third reviewer made the final determination (BM).
Data collection process
A data extraction form was developed for extracting data for the systematic review (Supplementary 1). All data items extracted were cross-checked. No attempt was made to contact the authors of papers that had missing data or unclear information.
Risk of bias
An assessment of study quality and risk of bias in the articles included in the review was conducted using the NewcastleeOttawa Scale, as recommended by the Cochrane Collaboration [8, 9] . The tool enables a maximum of nine stars to be awarded to a study. The content validity and inter-rater reliability of this tool has been established [9] . Two reviewers undertook this assessment independently (PR and RS). For any discrepancies, a third reviewer (BM) made the final determination. We were unable to determine level of bias associated with not including all HAIs in the review. Publications on the HAI incidence (or prevalence) varies considerably and includes the possibility of not publishing any data, not reporting on all HAIs a lack of sensitivity in HAI surveillance or methodological approaches used and a lack of validation. Such an issue is not limited to this study and is widespread in the area of HAI data, particularly in Australia [10e12].
Data analysis
All extracted data was entered into a comprehensive evidence-base table for descriptive analysis; 95% confidence intervals were calculated using Poisson regression. Meta-analysis was not performed due to the studies' heterogeneous methods, in particular, data collection. Meta-regression was not possible for the same reason.
Estimating the annual incidence of HAIs in Australia
We estimated the annual incidence of HAIs in Australia by extrapolating and modelling data from multi-centre studies that observed the same type of infection. Only multi-centre studies were used in the estimation, as they are likely to be more representative than single site studies. To estimate the annual number of cases of hospital onset Staphylococcus aureus bacteraemia and hospital identified Clostridium difficile, the total number of cases of each infection (identified in the included studies) was divided was divided by population data and subsequently multiplied by the Australian population. Population data was aggregate population of the states and territories contributing to the data. Population data for states territories and Australia was obtained from the Australian Bureau of Statistics, with 2016 population estimates used [13] .
To calculate the estimated number of cases of respiratory infections and surgical site infections, the raw data from studies was recalculated (if not reported) to determine the incidence (number of cases/number of procedures surveyed Â 100). Confidence intervals were also calculated. Where studies contained incidence data for more than one year, the data from the last reported year in the study was used for modelling to ensure the most recent data was used. If incidence data was not reported by year, the incidence for the entire study period was used for modelling.
Data from the Australian Institute of Health and Welfare and the Australian Commission on Safety and Quality was used to determine the number of procedures performed each year in Australia [14e17]. The calculated incidence was multiplied by the number of reported procedures per year, to give an estimated number of cases per year in Australia.
The number of healthcare associated urinary tract infections was reported as an incidence per 100 patient admissions in the literature. To determine the number of patient admissions per year in Australia, separation data from the Australian Institute of Health and Welfare was used [16] . Overnight separations are the closest available denominator to patient admissions. The reported incidence in the literature was multiplied by the number of overnight separations, to provide an estimated number of cases per year in Australia.
Results
Study selection
The initial database search identified 843 articles, with one additional article identified through hand searching. After duplicate articles were removed, 751 abstracts were reviewed and 105 articles were deemed suitable for a full text review. Twenty-four studies met the eligibility criteria and were included in this review. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow chart describing the papers identified from the search strategy is presented in Fig. 1 .
Risk of bias
When studies were assessed for risk of bias using the NewcastleeOttawa scale, the number of stars awarded to studies ranged from five to eight, the median being seven.
Study characteristics
A summary of the included articles with an overview of their key characteristics is provided in Table 1 . Of the 24 included articles, the most common infections surveyed were bloodstream infections (eight articles), surgical site or procedure infections (six articles) and respiratory infections (four articles). C. difficile infection was reported in three articles, with the remainder reporting multiple or other infections. There was variation in the methodological approaches used to identify infections, the definitions used to determine an infection, the patients included in the studies and the number of hospitals involved. Four of the articles involved hospitals in more than one state. Eight articles involved hospitals from Victoria only, making this state the most represented.
Results by type of infection Bloodstream infection
Four of the eight articles reported bloodstream infections at a hospital level; the remainder examined either bloodstream infections within an intensive care unit or patients who were undergoing a procedure. There was further variation in the types of bloodstream infections surveyed, with S. aureus bacteraemia the most common. There was some consistency in the methods used to determine the incidence of S. aureus bacteraemia. The reported incidence of hospital-acquired S. aureus bacteraemia was 0.77 per 10,000 bed days from New South Wales hospitals and 1.33 per 10,000 bed days from Queensland hospitals [18] . Mitchell et al. reported an incidence of 0.90 per 10,000 bed days for hospital-onset S. aureus bacteraemia [19] , but did not include hospitals from New South Wales, Queensland or Victoria. In this study by Mitchell et al. [19] , hospitalacquired S. aureus bacteraemia was defined as a S. aureus bacteraemia occurring more than 48 h after admission, whereas the article based on New South Wales and Queensland data used these criteria in addition to other criteria. The combined incidence of hospitalacquired S. aureus bacteraemia was 0.93 cases per 10,000 bed days (95% CI 0.90e0.96) [18, 19] . Other articles reporting bloodstream infection rates were limited to one hospital [20e23] or did not report the incidence of bloodstream infection [24] .
Surgical site or procedure related infection Three studies reported the incidence of surgical site infection in orthopaedic patients [25e27], but only two of these reported rates at a procedure level [25, 27] . Both of these studies included hospitals from Victoria and had overlapping study periods. In addition to these studies, Roth et al. [28] undertook a multi-centre study to determine the incidence of infectious complications following trans-rectal ultrasound. This study examined data from 31,209 patients from public and private hospitals over a five-year period and found that 1.73% of these patients were readmitted with a biopsy-related infection [28] .
Respiratory
The articles that reported respiratory HAI were heterogeneous in terms of the type of infections, the participants monitored and the methodological approaches used. Three were multi-centre studies but reported on different HAI: respiratory infections in acute stroke patients [29] , influenza [30] and pneumonia following cardiac surgery [31] .
C. difficile infection
Three multi-centre studies examined C. difficile infection with overlapping data collection periods [32e34]. The study by Slimings et al. [33] was conducted in seven Australian states and territories and involved 450 public hospitals. The incidence of hospital-identified C. difficile infection was 3.65 per 10,000 bed days, while the incidence of hospitalassociated C. difficile infection was 2.95 per 10,000 bed days (from five states and territories). This finding is consistent with that of Worth et al. [34] , who examined C. difficile infection in 136 healthcare facilities over a four-year period and found the incidence of healthcare-associated C. difficile infection to be 2.49 cases per 10,000 bed days. From the published data, we were unable to calculate the incidence of healthcare-associated C. difficile infection in the study undertaken in Western Australia [32] .
Other Three studies examined other HAI but only one study was multi-centre [35] . In this study examining the incidence of healthcare-associated urinary tract infections in eight hospitals over a four-year period, the authors found that 1.7% of admitted patients acquired a HAI of the urinary tract.
Estimates of yearly HAI incidence
Using data from multi-centre studies, we sought to estimate the number of HAI occurring each year in Australia (Table 2) . From the available data, we estimate 83,096 HAIs occur each year in Australia, however this number is a significant underestimation, it was only based on peerreviewed published multi-centre studies Included in our review. The 83,086 HAIs comprised of 71,186 urinary tract infections, 4902 healthcare associated C. difficile infections, 3946 surgical site infections, 1962 respiratory infections in acute stroke patients and 1100 hospital onset S. aureus bacteraemia infections.
Discussion
This paper presents the first systematic review of Australian HAI rates published in the peer-reviewed literature. We identified 24 studies published between 2010 and 2016. The infections surveyed, their definitions and the methods used varied considerably. To understand the magnitude of HAIs and associated burden of disease in Australia more fully, we attempted to estimate the incidence of HAIs using data from multi-centre studies.
A previous report estimated the incidence of HAIs in Australia to be 177,392 HAIs per year (headline number of 200,000 HAIs) [4] . This estimate was made several years ago and was based on one study conducted in one hospital; the best available data at that time. Unfortunately, the evidence base for estimating the incidence of HAIs in Australia remains lacking, certainly when using data from the peerreviewed literature. Our review has highlighted a myriad of different approaches to measure and define HAIs. In many instances, the data presented was limited, making comparisons or extrapolation of data impossible. In the absence of a national system for reporting there is a real need for those undertaking HAI surveillance e both at a hospital and a state level e to publish HAI surveillance data in the peer-reviewed literature. Accessing such information from government websites is fraught with challenges, including lack of detail about methods, delays in publishing data or failure to publish data. These issues do not apply to all states and territory health departments, but there are significant gaps across the country. This was also reflected in the results of our literature review, where more articles were published from Victorian data than any other state. Limited data is available from other states or on the MyHospitals website (www.myhospitals.gov.au).
National point prevalence studies are undertaken periodically in numerous countries including the United States, Canada and all European countries [2, 36, 37] . Australia is one of the few Organisation for Economic Co-operation and Development countries that does not undertake national HAI point prevalence studies, or have a national surveillance program [10] . These studies provide valuable insights into the most frequent HAIs: gastroenterological, respiratory, surgical site and urinary tract. Our review has identified few studies that explored the incidence of gastroenterological and respiratory infections, despite these being the most common. Surgical site infection data was well represented from studies from Victoria and urinary tract infection from New South Wales [26e28,35] . The data included in our review misses a large proportion of HAIs due to the absence of published incidence data.
Using data from the multi-centre studies to improve representativeness, we estimated the incidence of some types of HAIs. We estimate that each year in Australia, there are 71,186 urinary tract infections, 4902 C. difficile infections, 3946 surgical site infections, 1962 respiratory infections in acute stroke patients and 1100 S. aureus bacteraemia. These total 83,096 HAIs each year, but would be a very large underestimation given the lack of data on common infections. These estimates also come with considerable caveats due to the different methodologies and definitions. In the only national data available, our estimates for S. aureus bacteraemia are broadly consistent with that reported by the Australian Institute of Health and Welfare, who report 1440 cases of healthcare associated S. aureus bacteraemia in the 2015e16 financial year [38] . The difference is likely explained by case definitions (hospital onset Vs healthcare associated). Data from the United States and Europe suggests that pneumonia accounts for 21.8%e25.7% of HAIs: 7.8%e17.1% are gastroenterological infections, 9.9%e14.2% are bloodstream infections, and 3.1%e5.6% are ear, nose and throat infections [2, 36] . Our review only had data on the incidence of pneumonia from one group of patients (post-stroke) and one bloodstream infection (S. aureus bacteraemia). C. difficile infection was the only gastroenterological infection included in our review and we had no data on ear, nose or throat infections or many other HAIs such as central nervous system, reproductive tract and skin and soft tissue infections. Therefore, our estimate of 83,096 infections does not take into account a large proportion of pneumonia, gastroenterological, bloodstream infection or other infection data, thus potentially missing up to 50%e60% of infections. If that is the case, the incidence of HAIs in Australia may be closer to 165,000 per year.
One limitation of our review was that we did not source grey literature, specifically HAI data published on state and territory government websites. These data are difficult to locate, are reported differently and often used methodology that is not adequately described in an open forum. We recommend a follow-up review, focussing on collating and analysing this data. This approach was outside the scope of our review and available resources, and should be undertake in a future review.
Having a reliable estimate for the incidence of HAIs is important for a number of reasons. First, in an era of finite health resources, it helps prioritise infection prevention and control strategies. Second, it provides a benchmark against which future achievements or targets can be measured and evaluated. Third, it enables industry and those involved in healthcare innovation to have more reliable data for investment in products and research. Finally, it helps determine the resources required for HAI prevention and control relative to other health issues. On the eve of a global 'post-antibiotic era' [39] , the need for coordinated and systematic national surveillance and reporting of HAIs and established contributing factors, namely antimicrobial resistance and antibiotic usage, has never been greater.
We believe three concurrent strategies are required to address this gap. There needs to be a determination and action by state and national government bodies to achieve consensus on definitions, approaches to surveillance and transparent regular reporting. This should happen in parallel to the establishment of a national HAI surveillance program. There have been calls for a national centre for disease control [40] , potentially a national HAI surveillance program could be incorporated into such a centre. Finally, a national point prevalence study would provide valuable insight in the short term on the burden of HAIs in Australia. Given that the latter does not require a sophisticated study design and provides descriptive results, it has not been favourably supported by funding bodies. Whilst these suggested strategies have to date failed to eventuate, we call on all those involved in undertaking HAI surveillance in Australia to work collaboratively and publish data in the peer-reviewed literature.
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